Kuznetsov I. - list of publications

EFFECT OF NEW PHARMACEUTICAL COMPOSITION OF DIINDOLYLMETHANE ON LIFE EXPECTANCY OF XENOGRAFTS WITH TRANSPLANTED OVARIAN CANCER CELL LINE

Article

Pchelintseva O.I., Kiselev V.I., Drukh V.M., Udut V.V., Kuznetsov I.N., Muizhnek E.L.

Актуальные направления фундаментальных и прикладных исследований. CreateSpace. 2019. P. 5-7

MORPHOLOGICAL CHANGES IN THE PROSTATE TISSUE IN PATIENTS WITH PROSTATIC INTRAEPITHELIAL NEOPLASIA DURING CHEMOPROPHYLASIS USING A NEW PHARMACEUTICAL COMPOSITIONS OF THE DIINDOLYLMETHANEANE

Article

Kiselev V.I., Druh V.M., Kuznecov I.N., Muizhnek E.L., Andrianova E.A., Andreeva Y.Y., Allina D.O., Loran O.B., Frank G.A.

Экспериментальная и клиническая урология. Общество с ограниченной ответственностью МегаЛит Медика. 2015. P. 54-58

RESULTS OF MEDICAL THERAPY IN PATIENTS WITH CERVICAL INTRAEPITHELIAL NEOPLASIA I-II (CIN I-II)

Article

Ashrafyan L.A., Kiselev V.I., Aleshikova Olga, Ponomareva Yulia, Kuznetsov Igor, Vashakmadze S.L.

Akusherstvo i Ginekologiya. ООО «Бионика Медиа». 2015. P. 103-109

PHARMACOKINETIC STUDY OF THE PHARMACEUTICAL COMPOSITION BASED ON DIINDOLYLMETHANE IN FEMALE PATIENTS WITH ENDOMETRIAL HYPERPLASIA WITHOUT ATYPIA

Article

Andrianova E., Paltsev M., Kiselev V., Drukh V., Muyzhnek E., Kuznetsov I.

Biology and Medicine. AstonJournals. Vol. Vol7. 2015.

DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED MULTICENTER CLINICAL TRIAL (PHASE IIA) ON DIINDOLYLMETHANE'S EFFICACY AND SAFETY IN THE TREATMENT OF CIN: IMPLICATIONS FOR CERVICAL CANCER PREVENTION

Article

Ashrafian L., Suhikh G., Kiselev V., Paltsev M., Drukh V., Kuznetsov I., Muyzhnek E., Apolikhina I., Andrianova E.

EPMA Journal. BioMed Central Ltd.. Vol. Vol625. 2015.

A STUDY OF THE EFFICACY OF CERVIKON-DIM MEDICATION IN PATIENTS WITH GRADE 1-2 CERVICAL INTRAEPITHELIAL NEOPLASIA

Article

Ashrafian L.A., Sukhikh G.T., Kiselev V.I., Paltsev M.A., Apolikhina I.A., Drukh V.M., Kuznetsov I.N., Muyzhnek E.L., Andrianova E.A.

Вестник Российского научного центра рентгенорадиологии Минздрава России. Федеральное государственное бюджетное учреждение "Российский научный центр рентгенорадиологии" Министерства здравоохранения Российской Федерации. Vol. 15. 2015. P. 28-39

ИССЛЕДОВАНИЕ ВЛИЯНИЯ НОВОЙ ФАРМАЦЕВТИЧЕСКОЙ КОМПОЗИЦИИ 3,3-ДИИНДОЛИЛМЕТАНА НА СООТНОШЕНИЕ МЕТАБОЛИТОВ 2-ОНЕ1/16Α-ОНЕ1 У МЫШЕЙ С РАКОМ ЭНДОМЕТРИЯ

Article

Друх В.М., Кузнецов И.Н., Киселев В.И., Пчелинцева О.И., Муйжнек Е.Л.

Наука 21 века: новый подход. CreateSpace. 2015. P. 103-106

THE EFFICACY AND SAFETY OF DIINDOLYLMETHANE IN THE VAGINAL SUPPOSITORY DOSAGE FORM IN THE TREATMENT OF CERVICAL INTRAEPITHELIAL NEOPLASIA

Article

Ashrafian L.A., Sukhikh G.T., Kiselev V.I., Apolikhina I.A., Paltsev M.A., Drukh V.M., Kuznetsov I.N., Muyzhnek E.L.

Молекулярная медицина. Общество с ограниченной ответственностью Издательский дом Русский врач. 2015. P. 20-25

STUDY TO ASSESS SAFETY AND TOLERABILITY OF THE PHARMACEUTICAL COMPOSITION BASED ON DIINDOLYLMETHANE IN PATIENTS WITH ENDOMETRIAL HYPERPLASIA WITHOUT ATYPIA

Article

Andrianova E., Paltsev M., Kiselev V., Drukh V., Muyzhnek E., Kuznetsov I.

Biology and Medicine. AstonJournals. Vol. Vol7. 2015.

A STUDY OF SAFETY OF CERVIKON-DIM MEDICATION IN PATIENTS WITH CIN GRADE 1-2

Article

Drukh V.M., Kuznetsov I.N., Andrianova E.A., Baranovskiy P.M.

Современные проблемы науки и образования. Общество с ограниченной ответственностью "Издательский Дом "Академия Естествознания". 2015. P. 3-3

CONSERVATIVE THERAPY WITH CIN I-II VAGINAL SUPPOSITORIES CERVICON-DIM (INTERMEDIATE RESULTS OF A CLINICAL STUDY)

Article

Kiselyov V.I., Drukh V.M., Kuznetsov I.N., Muyahnek E.L., Apolikhina I.A., Gorbunova E.A., Pchelintseva O.I.

Медицинский совет. ООО «ГРУППА РЕМЕДИУМ». 2014. P. 140-143

STUDYING OF REPRODUCTIVE TOXICITY OF NEW PHARMACEUTICAL COMPOSITION ON THE BASIS OF 3,3′ - DIINDOLYLMETHANE

Article

Kiselev V.I., Drukh V.M., Kuznetsov I.N., Muyzhnek E.L., Gorbunova E.A., Pchelintseva O.I.

Медицина и образование в Сибири. 2014. 10 p.

EFFICACY OF THE NOVEL PHARMACEUTICAL COMPOSITION IN SUPPOSITORY FORM COMPRISING DIM IN PATIENTS WITH GRADE 1-2 CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN 1-2)

Article

Kiselev V.I., Ashrafyan L.A., Drukh V.M., Muyzhnek E.L., Kuznetsov I.N., Pchelintseva O.I., Andrianova E.A., Baranovskiy P.M.

Вестник Российского научного центра рентгенорадиологии Минздрава России. Федеральное государственное бюджетное учреждение "Российский научный центр рентгенорадиологии" Министерства здравоохранения Российской Федерации. 2014. 6 p.

STUDYING OF EFFICIENCY OF NEW PHARMACEUTICAL COMPOSITION OF DIINDOLYLMETHANE CONCERNING SUPPRESSION XENOGRAFT OF ENDOMETRIUM TUMOURS

Article

Kiselev V.I., Drukh V.M., Kuznetsov I.N., Muyzhnek E.L., Pchelintseva O.I.

Медицина и образование в Сибири. 2014. 24 p.

ASSESSMENT OF THE DRUG EFFICACY FOR TREATMENT OF CERVICAL INTRAEPITHELIAL NEOPLASIA GRADE I-II WITH PHARMACEUTICAL COMPOSITION CERVICON-DIM IN SUPPOSITORY FORM (INTERIM RESULTS OF A CLINICAL TRIAL)

Article

Kiselev V.I., Drukh V.M., Kuznetsov I.N., Muyzhnek E.L., Apolikhina I.A., Gorbunova E.A., Pchelintseva O.I.

Гинекология. Общество с ограниченной ответственностью Медицинское маркетинговое агентство МедиаМедика. Vol. 16. 2014. P. 58-62

COMPARATIVE PRECLINICAL PHARMACOKINETICS STUDY OF 3,3′-DIINDOLYLMETHANE FORMULATIONS: IS PERSONALIZED TREATMENT AND TARGETED CHEMOPREVENTION IN THE HORIZON?

Article

Paltsev Mikhail, Kiselev Vsevolod, Muyzhnek Ekaterina, Drukh Vadim, Kuznetsov Igor, Pchelintseva Olga

EPMA Journal. BioMed Central Ltd.. Vol. 4. 2013. P. 1-8

THE STUDYOF TOXIC AND ALLERGENIC PROPERTIES OF THE NEW PHARMACEUTICAL COMPOSITION OF DIINDOLYLMETHANE

Article

Druh V.M., Paltcev M.A., Kiselev V.I., Kuznetsov I.N., Ashrafyan L.A., Muyjnek E.L., Pchelintseva O.I.

Молекулярная медицина. Общество с ограниченной ответственностью Издательский дом Русский врач. 2013. P. 60-63

PRECLINICAL STUDY OF EFFECTS OF A NOVEL 3,3'-DIINDOLYLMETHANE BASED PHARMACEUTICAL COMPOSITION ON REPRODUCTIVE FUNCTION AND IMMUNE SYSTEM

Article

Kuznetsov I.N., Ashrafyan L.A., Kiselev V.I., Drukh V.M., Muyzhnek E.L., Pchelintseva O.I.

Вестник Российского научного центра рентгенорадиологии Минздрава России. Федеральное государственное бюджетное учреждение "Российский научный центр рентгенорадиологии" Министерства здравоохранения Российской Федерации. 2013. 14 p.

PROSECUTING AUTHORITIES AS SUBJECTS OF THE ADMINISTRATIVE PROCESS

Article

Kuznetsov I.

Мы говорим на юридическом английском, немецком, французском, испанском, китайском = We speak Legal English, German, French, Spanish, Chinese: Students' Annual Conference. Российский университет дружбы народов (РУДН). 2013. P. 52-53

LANGUAGE OF THE CHARACTERS OF PRIESTLEY'S PLAY "AN INSPECTOR CALLS

Article

Efimova Y., Kuznetsov I., Saparov N., Kazachan A., Bazhanov A.

Язык. Культура. Перевод. Российский университет дружбы народов (РУДН). 2010. P. 18-20

Кузнецов И.Н.

List of records

EFFECT OF NEW PHARMACEUTICAL COMPOSITION OF DIINDOLYLMETHANE ON LIFE EXPECTANCY OF XENOGRAFTS WITH TRANSPLANTED OVARIAN CANCER CELL LINE

MORPHOLOGICAL CHANGES IN THE PROSTATE TISSUE IN PATIENTS WITH PROSTATIC INTRAEPITHELIAL NEOPLASIA DURING CHEMOPROPHYLASIS USING A NEW PHARMACEUTICAL COMPOSITIONS OF THE DIINDOLYLMETHANEANE

RESULTS OF MEDICAL THERAPY IN PATIENTS WITH CERVICAL INTRAEPITHELIAL NEOPLASIA I-II (CIN I-II)

PHARMACOKINETIC STUDY OF THE PHARMACEUTICAL COMPOSITION BASED ON DIINDOLYLMETHANE IN FEMALE PATIENTS WITH ENDOMETRIAL HYPERPLASIA WITHOUT ATYPIA

DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED MULTICENTER CLINICAL TRIAL (PHASE IIA) ON DIINDOLYLMETHANE'S EFFICACY AND SAFETY IN THE TREATMENT OF CIN: IMPLICATIONS FOR CERVICAL CANCER PREVENTION

A STUDY OF THE EFFICACY OF CERVIKON-DIM MEDICATION IN PATIENTS WITH GRADE 1-2 CERVICAL INTRAEPITHELIAL NEOPLASIA

ИССЛЕДОВАНИЕ ВЛИЯНИЯ НОВОЙ ФАРМАЦЕВТИЧЕСКОЙ КОМПОЗИЦИИ 3,3-ДИИНДОЛИЛМЕТАНА НА СООТНОШЕНИЕ МЕТАБОЛИТОВ 2-ОНЕ1/16Α-ОНЕ1 У МЫШЕЙ С РАКОМ ЭНДОМЕТРИЯ

THE EFFICACY AND SAFETY OF DIINDOLYLMETHANE IN THE VAGINAL SUPPOSITORY DOSAGE FORM IN THE TREATMENT OF CERVICAL INTRAEPITHELIAL NEOPLASIA

STUDY TO ASSESS SAFETY AND TOLERABILITY OF THE PHARMACEUTICAL COMPOSITION BASED ON DIINDOLYLMETHANE IN PATIENTS WITH ENDOMETRIAL HYPERPLASIA WITHOUT ATYPIA

A STUDY OF SAFETY OF CERVIKON-DIM MEDICATION IN PATIENTS WITH CIN GRADE 1-2

CONSERVATIVE THERAPY WITH CIN I-II VAGINAL SUPPOSITORIES CERVICON-DIM (INTERMEDIATE RESULTS OF A CLINICAL STUDY)

STUDYING OF REPRODUCTIVE TOXICITY OF NEW PHARMACEUTICAL COMPOSITION ON THE BASIS OF 3,3′ - DIINDOLYLMETHANE

EFFICACY OF THE NOVEL PHARMACEUTICAL COMPOSITION IN SUPPOSITORY FORM COMPRISING DIM IN PATIENTS WITH GRADE 1-2 CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN 1-2)

STUDYING OF EFFICIENCY OF NEW PHARMACEUTICAL COMPOSITION OF DIINDOLYLMETHANE CONCERNING SUPPRESSION XENOGRAFT OF ENDOMETRIUM TUMOURS

ASSESSMENT OF THE DRUG EFFICACY FOR TREATMENT OF CERVICAL INTRAEPITHELIAL NEOPLASIA GRADE I-II WITH PHARMACEUTICAL COMPOSITION CERVICON-DIM IN SUPPOSITORY FORM (INTERIM RESULTS OF A CLINICAL TRIAL)

COMPARATIVE PRECLINICAL PHARMACOKINETICS STUDY OF 3,3′-DIINDOLYLMETHANE FORMULATIONS: IS PERSONALIZED TREATMENT AND TARGETED CHEMOPREVENTION IN THE HORIZON?

THE STUDYOF TOXIC AND ALLERGENIC PROPERTIES OF THE NEW PHARMACEUTICAL COMPOSITION OF DIINDOLYLMETHANE

PRECLINICAL STUDY OF EFFECTS OF A NOVEL 3,3'-DIINDOLYLMETHANE BASED PHARMACEUTICAL COMPOSITION ON REPRODUCTIVE FUNCTION AND IMMUNE SYSTEM

PROSECUTING AUTHORITIES AS SUBJECTS OF THE ADMINISTRATIVE PROCESS

LANGUAGE OF THE CHARACTERS OF PRIESTLEY'S PLAY "AN INSPECTOR CALLS

Other authors

Muyzhnek E.

Галкин В.Н.